Ángel Luis Rodríguez de la Cuerda, secretary general of AESEG, the trade association of generic producers in Spain, discusses the initiatives that the organization is undertaking to develop a true generic culture in the country and a new proposal changing the requirement for originator drugs to remain at the same price as generics when the patent expires.
Could you please share with our international audience the full picture of the Spanish generic sector?
"At the moment, eight out of ten patients in Spain consider generics a valuable alternative to branded products"
